FDCC
NARI

Foster Dykema Cabot & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Foster Dykema Cabot & Co’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43
Closed -$3K – 402
2023
Q2 		$3K Buy
+43
New +$2.71K ﹤0.01% 346

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Foster Dykema Cabot & Co's NARI Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2023, closing a stake of 43 shares — an estimated $3K sold.

Foster Dykema Cabot & Co first reported a position in NARI in Q2 2023 and held it in 1 quarter. The position peaked at $3K in Q2 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

  • Foster Dykema Cabot & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Foster Dykema Cabot & Co sold 43 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $3K.
  • Foster Dykema Cabot & Co first reported a position in Inari Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Foster Dykema Cabot & Co's Inari Medical, Inc. Common Stock position peaked at $3K in Q2 2023.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.